Jennison Associates LLC Myriad Genetics Inc Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$8.87 - $14.98 $15,930 - $26,904	1,796 Added 3.04%	60,811 $539,000
Q4 2024 Jan 24, 2025	BUY	$13.17 - $27.03 $459,014 - $942,076	34,853 Added 144.25%	59,015 $809,000
Q3 2024 Nov 08, 2024	BUY	$23.97 - $28.6 $579,163 - $691,033	24,162 New	24,162 $661,000
Q1 2019 May 10, 2019	SELL	$26.93 - $34.7 $441,328 - $568,663	-16,388 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$27.23 - $45.56 $29,108 - $48,703	-1,069 Reduced 6.12%	16,388 $476,000
Q3 2018 Nov 08, 2018	SELL	$37.57 - $50.34 $418,792 - $561,139	-11,147 Reduced 38.97%	17,457 $803,000
Q2 2018 Aug 02, 2018	BUY	$27.75 - $40.17 $17,010 - $24,624	613 Added 2.19%	28,604 $1.07 Million
Q1 2018 Apr 20, 2018	BUY	$28.83 - $41.01 $806,980 - $1.15 Million	27,991 New	27,991 $827,000

233

94.1M

460K

14.2K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $486M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.